Quarter Financials
Satsuma Pharmaceuticals, Inc. (STSA)
$1.1
0.00 (0.00%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
|---|
| Net Income | -10 | -23 | -15 | -16 | -15 | -16 | -13 | -12 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -222 | -212 | -189 | -174 | -157 | -142 | -126 | -113 |
|---|
|
Year
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
|---|
| Capital Expenditure | - | -0 | - | -0 | -0 | -0 | -0 | -0 |
|---|
| Net PPE | 0 | 0 | 7 | 7 | 7 | 7 | 8 | 7 |
|---|
|
Year
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
|---|
| New Purchases | -46 | -15 | -19 | -2 | -22 | -2 | -22 | -1 |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|